Vey Tosal, 100+0,05mg/ml, Solution for injection
Vey Tosal, 100+0,05mg/ml, Solution for injection
Authorised
- Butafosfan
- Cyanocobalamin
Product identification
Medicine name:
Vey Tosal, 100+0,05mg/ml, Solution for injection
Vey Tosal, 100+0,05mg/ml, Injekční roztok
Active substance:
- Butafosfan
- Cyanocobalamin
Target species:
-
Cattle
-
Horse
-
Dog
-
Cat
Route of administration:
-
Intravenous use
-
Subcutaneous use
-
Intramuscular use
Product details
Active substance and strength:
-
Butafosfan100.00milligram(s)1.00millilitre(s)
-
Cyanocobalamin0.05milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intravenous use
- Cattle
-
Meat and offal0day
-
Milk0hour
-
- Horse
-
Meat and offal0day
-
Milk0hour
-
- Dog
- Cat
-
Subcutaneous use
- Dog
- Cat
-
Intramuscular use
- Dog
- Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QA12CX99
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Czechia
Available in:
-
Czechia
Package description:
- Glass Vial 1 x 250.0 millilitre(s)
- Glass Vial 1 x 100.0 millilitre(s)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Veyx Pharma GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Veyx Pharma GmbH
Responsible authority:
- Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
- 96/023/23-C
Date of authorisation status change:
Reference member state:
-
Czechia
Procedure number:
- CZ/V/0172/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Malta
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 26/09/2023
Czech (PDF)
Published on: 27/11/2023
eu-puar-czv0172001-mr-vey_tosal-en.pdf
English (PDF)
Download Published on: 16/11/2023
How useful was this page?: